SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form S-1 - General form for registration of securities under the Securities Act of 1933:
SEC Accession No. 0001437749-22-029932
Filing Date
2022-12-30
Accepted
2022-12-30 16:15:56
Documents
20

Document Format Files

Seq Description Document Type Size
1 FORM S-1 nby20221214_s1.htm   iXBRL S-1 502100
2 EXHIBIT 5.1 ex_456732.htm EX-5.1 13422
3 EXHIBIT 23.1 ex_456733.htm EX-23.1 2677
4 EXHIBIT 23.2 ex_456734.htm EX-23.2 2949
5 EXHIBIT FILING FEES ex_456735.htm EX-FILING FEES 15000
10 ex_456732img001.jpg GRAPHIC 4215
11 nby20221214_s1img001.jpg GRAPHIC 5836
12 nby20221214_s1img002.jpg GRAPHIC 6779
  Complete submission text file 0001437749-22-029932.txt   755807

Data Files

Seq Description Document Type Size
6 XBRL TAXONOMY EXTENSION SCHEMA nby-20221230.xsd EX-101.SCH 3594
7 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE nby-20221230_def.xml EX-101.DEF 8911
8 XBRL TAXONOMY EXTENSION LABEL LINKBASE nby-20221230_lab.xml EX-101.LAB 11767
9 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE nby-20221230_pre.xml EX-101.PRE 8682
14 EXTRACTED XBRL INSTANCE DOCUMENT nby20221214_s1_htm.xml XML 1987
Mailing Address 2000 POWELL STREET, SUITE 1150 EMERYVILLE CA 94608
Business Address 2000 POWELL STREET, SUITE 1150 EMERYVILLE CA 94608 (510) 899-8800
NovaBay Pharmaceuticals, Inc. (Filer) CIK: 0001389545 (see all company filings)

IRS No.: 680454536 | State of Incorp.: DE | Fiscal Year End: 1231
Type: S-1 | Act: 33 | File No.: 333-269083 | Film No.: 221502145
SIC: 2834 Pharmaceutical Preparations